Literature DB >> 9251709

Remanipulation of forearm fractures in children.

C F Chan1, B M Meads, R O Nicol.   

Abstract

AIMS: To determine whether operator experience or time of operation affects the outcome of fractures of the forearm in the paediatric age group as measured by the need for remanipulation.
METHODS: A retrospective analysis of 1155 children with forearm fractures requiring manipulation was undertaken.
RESULTS: The remanipulation rate for these 1155 children was 136 or 11.7%. There was a significant difference in those fractures requiring remanipulation dependent upon the experience of the operator and the time of day the procedure was performed. The lowest rate of remanipulation was obtained by senior registrars operating between the hours of 0800-1700 (6/113 or 5.3%). The highest rate was found to be junior registrars between the hours of 1700-2200 (39/167 or 23.3%). It is especially interesting to note the relatively low rate (31/437 or 7.1%) obtained by junior registrars during the night shift (2200-0800 hours).
CONCLUSIONS: The current overall remanipulation rate is acceptable. The low rate between 2200-0800 hours means rescheduling of these patients is unnecessary. The rate for junior registrars between 1700-2200 hours needs to be improved.

Entities:  

Mesh:

Year:  1997        PMID: 9251709

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  2 in total

1.  Conversion to below-elbow cast after 3 weeks is safe for diaphyseal both-bone forearm fractures in children.

Authors:  Joost W Colaris; Jan Hein Allema; L Ulas Biter; Max Reijman; Cees P van de Ven; Mark R de Vries; Rolf M Bloem; Albert J H Kerver; Jan A N Verhaar
Journal:  Acta Orthop       Date:  2013-10-31       Impact factor: 3.717

2.  Factors Responsible for Redisplacement of Pediatric Forearm Fractures Treated by Closed Reduction and Cast: Role of casting indices and three point index.

Authors:  Rajesh Arora; Puneet Mishra; Aditya Nath Aggarwal; Rahul Anshuman; Ravi Sreenivasan
Journal:  Indian J Orthop       Date:  2018 Sep-Oct       Impact factor: 1.251

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.